Sojournix Appoints Ruth Thieroff-Ekerdt Chief Medical Officer

Ruth Thieroff-Ekerdt has been appointed senior vice president and chief medical officer of Sojournix, a Waltham, MA-based women’s health company. She most recently worked at Kaleido Biosciences as its chief medical officer, a position she previously held at Strongbridge Biopharma and Aptalis Pharmaceuticals. Last month, Sojournix closed a $44 million Series C round of funding. The company’s lead drug candidate, SJX-653, is in early-stage testing as a treatment for “hot flashes” due to menopause.





READ  Soldier Bug Could Help Combat Antibiotic Resistance

Categories: Biotech, Boston, Industry, Life Sciences

Tagged as: , ,

Leave a Reply